{
  "abstract": "Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a major cause of morbidity and mortality in patients with rheumatoid arthritis. This study evaluated the 1-year retention rates of Janus kinase (JAK) inhibitors in patients with RA-ILD and investigated their effects in experimental pulmonary fibrosis and human lung fibroblasts. One-year retention rates were assessed in patients with RA-ILD treated with baricitinib (BAR), peficitinib (PEF), filgotinib (FIL), upadacitinib, or tofacitinib. Pulmonary fibrosis was induced by bleomycin (BLM) in C57BL/6J mice, followed by treatment with BAR, PEF, or FIL. Survival, body weight, computed tomography findings, and histopathology were evaluated. Normal human lung fibroblasts (NHLFs) were stimulated with the interleukin (IL)-6/IL-6 receptor and treated with each JAK inhibitor. STAT1, STAT3, and STAT5 phosphorylation and the production of vascular endothelial growth factor (VEGF), transforming growth factor-β1, and fractalkine were assessed. JAK inhibitor 1-year retention rates did not differ significantly between patients with and without RA-ILD. In the BLM model, BAR attenuated pulmonary inflammation, preserved body weight, and improved survival compared with PEF and FIL. In NHLFs, BAR most effectively suppressed IL-6-induced STAT3 phosphorylation and VEGF production. These findings suggest that BAR may exert protective effects in experimental pulmonary fibrosis through suppression of the IL-6/STAT3/VEGF axis.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Pathogenesis and Translational Medicine, Showa Medical University Graduate School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan",
    "Division of Pathogenesis and Translational Medicine, Department of Clinical Pharmacy, Showa Medical University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan",
    "Division of Rheumatology, Department of Medicine, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan",
    "Department of Microbiology and Immunology, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan",
    "Division of Nephrology, Department of Medicine, Showa Medical University Graduate School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 10,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Hiroyuki Kojima",
      "orcid": "0009-0000-3104-5154"
    },
    {
      "affs": [
        0
      ],
      "name": "Haruka Nakamura"
    },
    {
      "affs": [
        0
      ],
      "name": "Kohei Maeda",
      "orcid": "0000-0003-4195-6183"
    },
    {
      "affs": [
        0
      ],
      "name": "Kosuke Sakurai",
      "orcid": "0000-0001-5376-4707"
    },
    {
      "affs": [
        0
      ],
      "name": "Toshihiro Tanioka"
    },
    {
      "affs": [
        1
      ],
      "name": "Maina Miyatani"
    },
    {
      "affs": [
        2
      ],
      "name": "Kuninobu Wakabayashi",
      "orcid": "0000-0002-9554-4742"
    },
    {
      "affs": [
        2
      ],
      "name": "Yusuke Miwa",
      "orcid": "0000-0001-5956-7974"
    },
    {
      "affs": [
        3,
        4
      ],
      "name": "Masayuki Iyoda",
      "orcid": "0000-0002-1153-3000"
    },
    {
      "affs": [
        0,
        2
      ],
      "name": "Takeo Isozaki",
      "orcid": "0000-0002-8621-7643"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/aq49zth18v2jf.bib",
  "cited_by": 0,
  "doi": "10.3390/ijms272210243",
  "fulltext_url": null,
  "id": "aq49zth18v2jf",
  "issns": [
    "1422-0067"
  ],
  "landing_url": "https://www.mdpi.com/1422-0067/27/22/10243",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-15",
  "publisher": "MDPI AG",
  "ris": "https://research.draconitic.com/paper/aq49zth18v2jf.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:24:18Z",
      "native_id": "10.3390/ijms272210243",
      "source": "crossref",
      "url": "https://www.mdpi.com/1422-0067/27/22/10243"
    }
  ],
  "subjects": [
    {
      "field": "biochemistry",
      "origin": "issn:1422-0067",
      "subfield": "general"
    }
  ],
  "title": "Translational Study on the Effects of Janus Kinase Inhibitors on Interstitial Lung Disease Complicated with Rheumatoid Arthritis",
  "title_text": "Translational Study on the Effects of Janus Kinase Inhibitors on Interstitial Lung Disease Complicated with Rheumatoid Arthritis",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:24:18Z",
  "url": "https://research.draconitic.com/paper/aq49zth18v2jf",
  "venue": "International Journal of Molecular Sciences",
  "versions": []
}